Lista de obras -

A genomics-based approach to assessment of vaccine safety and immunogenicity in children.

artículo científico publicado en 2012

A longitudinal study of natural antibody development to pneumococcal surface protein A families 1 and 2 in Papua New Guinean Highland children: a cohort study

artículo científico publicado en 2016

Adverse environmental conditions influence age-related innate immune responsiveness

scientific article published on 30 May 2009

An observational study of the reactogenicity and immunogenicity of 13-valent pneumococcal conjugate vaccine in women of childbearing age in Papua New Guinea

scientific article published on 25 November 2020

Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial

scientific article published on 25 September 2018

Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea

scientific article published on 30 April 2020

Comparison of neonatal T regulatory cell function in Papua New Guinean and Australian newborns ⬇️

artículo científico publicado el 23 de diciembre de 2011

Corrigendum: Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea

artículo científico publicado en 2020

Differences in innate immune function between allergic and nonallergic children: New insights into immune ontogeny ⬇️

artículo científico publicado el 18 de noviembre de 2010

Dynamic molecular changes during the first week of human life follow a robust developmental trajectory

artículo científico publicado en 2019

Effect of early carriage of Streptococcus pneumoniae on the development of pneumococcal protein-specific cellular immune responses in infancy.

artículo científico publicado en 2012

Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen®) and tetanus, reduced-dose diphtheria combination (TdaP, Boostagen®) vaccine for immunization of adolescents and adu

artículo científico publicado en 2020

Epidemiology of Escherichia coli Bacteremia: A Systematic Literature Review

scientific article published on 14 May 2020

Immune responses induced by repeated treatment do not result in protective immunity to Schistosoma haematobium: interleukin (IL)-5 and IL-10 responses

artículo científico publicado en 2002

Immunization of newborns with bacterial conjugate vaccines ⬇️

artículo científico publicado el 19 de junio de 2012

Immunogenicity and Immune Memory after a Pneumococcal Polysaccharide Vaccine Booster in a High-Risk Population Primed with 10-Valent or 13-Valent Pneumococcal Conjugate Vaccine: A Randomized Controlled Trial in Papua New Guinean Children

artículo científico publicado en 2019

Impaired innate immunity predicts frailty in old age. The Leiden 85-plus study

artículo científico publicado en 2004

Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age.

artículo científico publicado en 2007

Inflammation underlying cardiovascular mortality is a late consequence of evolutionary programming

artículo científico publicado en 2004

Intestinal parasitic infections and anaemia among pregnant women in the highlands of Papua New Guinea

artículo científico publicado en 2013

Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren

artículo científico publicado en 2004

Maternal antibodies to pneumolysin but not to pneumococcal surface protein A delay early pneumococcal carriage in high-risk Papua New Guinean infants

artículo científico publicado en 2009

Neonatal antigen-presenting cells are functionally more quiescent in children born under traditional compared with modern environmental conditions

scientific article published on 19 July 2012

Neonatal innate cytokine responses to BCG controlling T-cell development vary between populations.

artículo científico publicado en 2009

Neonatal pneumococcal conjugate vaccine immunization primes T cells for preferential Th2 cytokine expression: a randomized controlled trial in Papua New Guinea

artículo científico publicado en 2009

Ontogeny of Toll-Like and NOD-Like Receptor-Mediated Innate Immune Responses in Papua New Guinean Infants ⬇️

artículo científico publicado el 23 de mayo de 2012

Pneumococcal conjugate vaccination at birth in a high-risk setting: no evidence for neonatal T-cell tolerance

artículo científico publicado en 2011

Pneumococcal conjugate vaccine primes mucosal immune responses to pneumococcal polysaccharide vaccine booster in Papua New Guinean children

artículo científico publicado en 2020

Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination

artículo científico publicado en 2017

Predicting future trends in the burden of pertussis in the 21st century: implications for infant pertussis and the success of maternal immunization

artículo científico publicado en 2015

Preparing for Life: Plasma Proteome Changes and Immune System Development During the First Week of Human Life

artículo científico publicado en 2020

Presymptomatic differences in Toll-like receptor function in infants who have allergy.

artículo científico publicado en 2008

Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea

artículo científico publicado en 2017

Responses to Toll-like receptor ligands in children living in areas where schistosome infections are endemic

artículo científico publicado en 2004

Safety and Immunogenicity of Neonatal Pneumococcal Conjugate Vaccination in Papua New Guinean Children: A Randomised Controlled Trial ⬇️

artículo científico publicado el 22 de febrero de 2013

Safety and Immunogenicity of Pneumococcal Conjugate Vaccines in a High-risk Population: A Randomized Controlled Trial of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccine in Papua New Guinean Infants

artículo científico publicado en 2019

Selection for genetic variation inducing pro-inflammatory responses under adverse environmental conditions in a Ghanaian population

artículo científico publicado en 2009

Transiently increased IgE responses in infants and pre-schoolers receiving only acellular Diphtheria-Pertussis-Tetanus (DTaP) vaccines compared to those initially receiving at least one dose of cellular vaccine (DTwP) - Immunological curiosity or ca

artículo científico publicado en 2016

Lista de obras de

A genomics-based approach to assessment of vaccine safety and immunogenicity in children.

A longitudinal study of natural antibody development to pneumococcal surface protein A families 1 and 2 in Papua New Guinean Highland children: a cohort study

Adverse environmental conditions influence age-related innate immune responsiveness

An observational study of the reactogenicity and immunogenicity of 13-valent pneumococcal conjugate vaccine in women of childbearing age in Papua New Guinea

Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial

Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea

Comparison of neonatal T regulatory cell function in Papua New Guinean and Australian newborns ⬇️

Corrigendum: Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea

Differences in innate immune function between allergic and nonallergic children: New insights into immune ontogeny ⬇️

Dynamic molecular changes during the first week of human life follow a robust developmental trajectory

Effect of early carriage of Streptococcus pneumoniae on the development of pneumococcal protein-specific cellular immune responses in infancy.

Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen®) and tetanus, reduced-dose diphtheria combination (TdaP, Boostagen®) vaccine for immunization of adolescents and adu

Epidemiology of Escherichia coli Bacteremia: A Systematic Literature Review

Immune responses induced by repeated treatment do not result in protective immunity to Schistosoma haematobium: interleukin (IL)-5 and IL-10 responses

Immunization of newborns with bacterial conjugate vaccines ⬇️

Immunogenicity and Immune Memory after a Pneumococcal Polysaccharide Vaccine Booster in a High-Risk Population Primed with 10-Valent or 13-Valent Pneumococcal Conjugate Vaccine: A Randomized Controlled Trial in Papua New Guinean Children

Impaired innate immunity predicts frailty in old age. The Leiden 85-plus study

Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age.

Inflammation underlying cardiovascular mortality is a late consequence of evolutionary programming

Intestinal parasitic infections and anaemia among pregnant women in the highlands of Papua New Guinea

Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren

Maternal antibodies to pneumolysin but not to pneumococcal surface protein A delay early pneumococcal carriage in high-risk Papua New Guinean infants

Neonatal antigen-presenting cells are functionally more quiescent in children born under traditional compared with modern environmental conditions

Neonatal innate cytokine responses to BCG controlling T-cell development vary between populations.

Neonatal pneumococcal conjugate vaccine immunization primes T cells for preferential Th2 cytokine expression: a randomized controlled trial in Papua New Guinea

Ontogeny of Toll-Like and NOD-Like Receptor-Mediated Innate Immune Responses in Papua New Guinean Infants ⬇️

Pneumococcal conjugate vaccination at birth in a high-risk setting: no evidence for neonatal T-cell tolerance

Pneumococcal conjugate vaccine primes mucosal immune responses to pneumococcal polysaccharide vaccine booster in Papua New Guinean children

Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination

Predicting future trends in the burden of pertussis in the 21st century: implications for infant pertussis and the success of maternal immunization

Preparing for Life: Plasma Proteome Changes and Immune System Development During the First Week of Human Life

Presymptomatic differences in Toll-like receptor function in infants who have allergy.

Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea

Responses to Toll-like receptor ligands in children living in areas where schistosome infections are endemic

Safety and Immunogenicity of Neonatal Pneumococcal Conjugate Vaccination in Papua New Guinean Children: A Randomised Controlled Trial ⬇️

Safety and Immunogenicity of Pneumococcal Conjugate Vaccines in a High-risk Population: A Randomized Controlled Trial of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccine in Papua New Guinean Infants

Selection for genetic variation inducing pro-inflammatory responses under adverse environmental conditions in a Ghanaian population

Transiently increased IgE responses in infants and pre-schoolers receiving only acellular Diphtheria-Pertussis-Tetanus (DTaP) vaccines compared to those initially receiving at least one dose of cellular vaccine (DTwP) - Immunological curiosity or ca